[Bonraybio-GISA] February 2026 Revenue: ~TWD 27 Million (YoY +13.0%)
Bonraybio-GISA (6955) announced its financial report for February 2026. The company's revenue for the month was 26,906 thousand TWD (approx. 27 million TWD), a 13.0% increase compared to the same period last year. Bonraybio-GISA is a company specializing in the biotechnology and healthcare industry.
📋 Article Processing Timeline
- 📰 Published: February 1, 2026 at 09:00
- 🔍 Collected: April 7, 2026 at 08:00 (1559h 0m after Published)
- 🤖 AI Analyzed: April 8, 2026 at 00:19 (16h 19m after Collected)
Stock Code: 6955
Company Name: Bonraybio-GISA
Industry: Biotechnology & Healthcare
Data Period: 2026-02
Revenue for the Month: 26,906 thousand TWD
YoY Change: +13.0%
Company Name: Bonraybio-GISA
Industry: Biotechnology & Healthcare
Data Period: 2026-02
Revenue for the Month: 26,906 thousand TWD
YoY Change: +13.0%
FAQ
What was Bonraybio-GISA's revenue for February 2026?
Bonraybio-GISA's revenue for February 2026 was approximately TWD 27 million, or 26,906 thousand TWD.
How did Bonraybio-GISA's February 2026 revenue compare to the previous year?
Bonraybio-GISA's revenue in February 2026 showed a year-over-year increase of 13.0%.
What is the stock code for Bonraybio-GISA?
The stock code for Bonraybio-GISA is 6955.
In which industry does Bonraybio-GISA operate?
Bonraybio-GISA operates in the Biotechnology & Healthcare industry.
What is the specific revenue figure reported for Bonraybio-GISA in February 2026?
The specific revenue figure reported for Bonraybio-GISA in February 2026 is 26,906 thousand TWD.